Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Randomized, Blinded Study of Fluorescence Detection of Pediatric Primary Central Nervous System Tumors in Subjects Receiving Tozuleristide and Imaged With the Canvas System

NCT03579602 is registered in ClinicalTrials.gov with Blaze Bioscience Inc. as lead sponsor.

NCT NCT03579602
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03579602 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Randomized, Blinded Study of Fluorescence Detection of Pediatric Primary Central Nervous System Tumors in Subjects Receiving Tozuleristide and Imaged With the Canvas System
Lead sponsor
Blaze Bioscience Inc.
Phase
Phase 2/3
Overall status
Completed
Start date
November 26, 2018
Completion date
June 13, 2022
Enrollment
118 (actual)
Sites
9

Conditions

As the registry lists them; a condition with its own page is linked.

pediatric central nervous system tumor